Mylan Loses Bid To Dismiss MS Drug Patent Suit
Mylan Pharmaceuticals Inc. lost a bid Monday to dismiss Teva Pharmaceutical Industries Ltd.'s patent suit over the multiple-sclerosis drug Copaxone when a New York federal judge found that the drug's patents...To view the full article, register now.
Already a subscriber? Click here to view full article